HIGHLIGHTS
- who: Azita Hekmatdoost from the of Sharjah, United Northwestern, United States have published the research: Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial, in the Journal: Nutritional intake and physical activity
- what: Regarding the age range, the authors aimed to avoid middle-aged and elderly participants due to the lower availability of this population for fasting or adherence to new dietary models that yield habitual changes. In a meta-analysis, CK-18 levels proved to be an important tool for diagnosing NAFLD, especially non-alcoholic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.